Subtype
Liver Neoplasm
CI-CAN-00001077Explore in graph →
Non-malignant930 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001077Explore in graph →
Clinical trials
4,334 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02709070 | Resection+Highly Purified CTL Versus Resection Alone for HCC | unknown | Phase 3 | 210 | Sun Yat-sen UniversityOTHER | 0 | Mar 16, 2016 | clinicaltrials |
| NCT02537158 | Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection | unknown | N/A | 90 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT02210182 |
| A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma |
| completed |
| Phase 1 |
| 29 |
| Oncozyme Pharma Inc.INDUSTRY |
| 1 |
| Mar 14, 2016 |
| clinicaltrials |
| NCT00877071 | LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed(HCC) | completed | Phase 2 | 2 | University of PittsburghOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00987935 | A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients | completed | Phase 2 | 134 | Boehringer IngelheimINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT01147380 | Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation(MIAMINK) | completed | Phase 1 | 18 | Seigo NishidaOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01466881 | Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 2 | Mar 10, 2016 | clinicaltrials |
| NCT02702323 | Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study | unknown | Phase 2 / Phase 3 | 40 | Zhejiang Cancer HospitalOTHER | 0 | Mar 8, 2016 | clinicaltrials |
| NCT02101593 | Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer | completed | Phase 1 | 8 | Polaris GroupINDUSTRY | 1 | Mar 4, 2016 | clinicaltrials |
| NCT00055692 | Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 29, 2016 | clinicaltrials |
| NCT02447263 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer | completed | Phase 1 / Phase 2 | 87 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02449109 | Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02678013 | RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC | unknown | Phase 3 | 210 | Ming KuangOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02687113 | Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion | completed | N/A | 240 | Seoul National University HospitalOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00582400 | A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver | terminated | Phase 2 | 9 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00774501 | The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy | completed | N/A | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01539681 | Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy(STELLA) | completed | — | 234 | BayerINDUSTRY | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00532441 | Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas | terminated | Phase 2 | 25 | Gabi Chiorean, MDOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT01594125 | Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma | completed | Phase 1 | 30 | Boehringer IngelheimINDUSTRY | 1 | Feb 12, 2016 | clinicaltrials |
| NCT00732836 | Hepatic Arterial Infusion (HAI) of Abraxane | completed | Phase 1 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT01177631 | Proteomic Analysis of Human Hepatocellular Carcinoma | completed | N/A | 5 | Far Eastern Memorial HospitalOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT02213692 | Comparative Study on Liver Resection Between Harmonic Scalpel Versus Crush-clamping Method | terminated | — | 120 | Hui-Chuan SunOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT02672488 | Metformin Plus Sorafenib for Advanced HCC | unknown | Phase 2 | 82 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01567631 | Classical Procedure Versus Intrahepatic Glisson's Approach(LAHIGA) | unknown | N/A | 80 | Shuguo Zheng, MDOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT01801852 | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | unknown | N/A | 300 | Chinese PLA General HospitalOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02309788 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis(RHCC) | unknown | — | 100 | Guangxi Medical UniversityOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00109954 | Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 120 | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00712790 | Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 35 | Singapore Clinical Research InstituteOTHER | 4 | Jan 6, 2016 | clinicaltrials |
| NCT02647047 | Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery | unknown | N/A | 40 | Ospedale San RaffaeleOTHER | 1 | Jan 6, 2016 | clinicaltrials |
| NCT02403544 | Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | unknown | Phase 1 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02552745 | Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization | completed | — | 200 | Sun Yat-sen UniversityOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT02613156 | Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma | completed | — | 25 | Sun Yat-sen UniversityOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT02632006 | Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02632188 | Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 60 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT02638857 | Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 60 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib(REACH) | completed | Phase 3 | 565 | Eli Lilly and CompanyINDUSTRY | 27 | Dec 28, 2015 | clinicaltrials |
| NCT00746655 | SBRT + TACE for Primary Hepatocellular Carcinoma | withdrawn | N/A | 0 | University of PittsburghOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT02156700 | Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors | completed | — | 196 | University Hospital DubravaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT02631499 | Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation | unknown | Phase 4 | 256 | Fudan UniversityOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01393197 | Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)(TACE-KMG) | unknown | N/A | 2,480 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT01715532 | Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02133079 | Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 20 | Cure&Sure Biotech Co., LTDINDUSTRY | 1 | Dec 11, 2015 | clinicaltrials |
| NCT02616926 | Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma | unknown | N/A | 538 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT01232296 | A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment | completed | Phase 2 | 162 | Novartis PharmaceuticalsINDUSTRY | 7 | Dec 4, 2015 | clinicaltrials |
| NCT00669136 | Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | terminated | Phase 1 | 2 | Lisa H. Butterfield, Ph.D.OTHER | 1 | Dec 3, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Mar 16, 2016source: clinicaltrials